These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8769716)

  • 1. Point mutation of the p53 gene is an infrequent event in untreated prostate cancer.
    Kunimi K; Amano T; Uchibayashi T
    Cancer Detect Prev; 1996; 20(3):218-22. PubMed ID: 8769716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An uncertain role for p53 gene alterations in human prostate cancers.
    Brooks JD; Bova GS; Ewing CM; Piantadosi S; Carter BS; Robinson JC; Epstein JI; Isaacs WB
    Cancer Res; 1996 Aug; 56(16):3814-22. PubMed ID: 8706029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 is mutated in a subset of advanced-stage prostate cancers.
    Bookstein R; MacGrogan D; Hilsenbeck SG; Sharkey F; Allred DC
    Cancer Res; 1993 Jul; 53(14):3369-73. PubMed ID: 8324747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.
    Isaacs WB; Carter BS; Ewing CM
    Cancer Res; 1991 Sep; 51(17):4716-20. PubMed ID: 1873816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A hot-spot mutation of p53 gene in nasopharyngeal carcinoma].
    Chen R; Zhu D; Yin W
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):401-4. PubMed ID: 8697986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
    Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S
    Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of p53 mutations with metastatic prostate cancer.
    Eastham JA; Stapleton AM; Gousse AE; Timme TL; Yang G; Slawin KM; Wheeler TM; Scardino PT; Thompson TC
    Clin Cancer Res; 1995 Oct; 1(10):1111-8. PubMed ID: 9815901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of the tumor suppressor gene p53 in human prostate and bladder cancers--investigation by temperature gradient gel electrophoresis (TGGE).
    Schlechte HH; Schnorr D; Löning T; Rudolph BD; Pohrt UM; Loening SA
    J Urol; 1997 Mar; 157(3):1049-53. PubMed ID: 9072541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers.
    Voeller HJ; Augustus M; Madike V; Bova GS; Carter KC; Gelmann EP
    Cancer Res; 1997 Oct; 57(20):4455-9. PubMed ID: 9377551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.
    Stapleton AM; Timme TL; Gousse AE; Li QF; Tobon AA; Kattan MW; Slawin KM; Wheeler TM; Scardino PT; Thompson TC
    Clin Cancer Res; 1997 Aug; 3(8):1389-97. PubMed ID: 9815823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant point mutation of tumor suppressor gene p53 and oncogene c-N-ras in malignant neuroendocrine pancreatic tumor.
    Hrasćan R; Pavelić K; Pavicić D; Krizanac S; Stajcer-Sittić V; Pecur L; Spaventi S; Klimpfinger M; Pavelić J
    Anticancer Res; 1996; 16(6B):3761-6. PubMed ID: 9042254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
    Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
    Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus.
    Lee JY; Dong SM; Shin MS; Kim SY; Lee SH; Kang SJ; Lee JD; Kim CS; Kim SH; Yoo NJ
    Biochem Biophys Res Commun; 1997 Aug; 237(3):667-72. PubMed ID: 9299424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog.
    Van Leeuwen IS; Hellmèn E; Cornelisse CJ; Van den Burgh B; Rutteman GR
    Anticancer Res; 1996; 16(6B):3737-44. PubMed ID: 9042250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines.
    Zheng L; Wang F; Qian C; Neumann RM; Cheville JC; Tindall DJ; Liu W
    Hum Mutat; 2006 Oct; 27(10):1062-3. PubMed ID: 16941491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential.
    Navone NM; Labate ME; Troncoso P; Pisters LL; Conti CJ; von Eschenbach AC; Logothetis CJ
    J Urol; 1999 Jan; 161(1):304-8. PubMed ID: 10037428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.
    Dong M; Nio Y; Yamasawa K; Toga T; Yue L; Harada T
    J Surg Oncol; 2003 Feb; 82(2):111-20. PubMed ID: 12561067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.
    Langerød A; Bukholm IR; Bregård A; Lønning PE; Andersen TI; Rognum TO; Meling GI; Lothe RA; Børresen-Dale AL
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1684-8. PubMed ID: 12496062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.